✦ LIBER ✦

Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR–ABL-positive acute lymphoblastic leukemia—retrospective analysis of Polish Adult Leukemia Group (PALG)

✍ Scribed by A. Wrzesień-Kuś; T. Robak; A. Pluta; M. Zwolińska; E. Wawrzyniak; A. Wierzbowska; A. Skotnicki; B. Jakubas; J. Hołowiecki; K. Nowak; K. Kuliczkowski; G. Mazur; O. Haus; A. Dmoszyńska; M. Adamczyk-Cioch; W. W. Jędrzejczak; M. Paluszewska; L. Konopka; G. Pałynyczko

Publisher: Springer
Year: 2006
Tongue: English
Weight: 145 KB
Volume: 85
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-006-0099-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The extent of minimal residual disease r

The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia

✍ Seok Lee; Yoo-Jin Kim; Nak-Gyun Chung; Jihyang Lim; Dong-Gun Lee; Hee-Je Kim; Ch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 2 views

## Abstract ## BACKGROUND: Previously, the authors demonstrated the positive impact of imatinib on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph‐positive ALL). Here, the authors analyzed for risk factors that af